Bone and Mineral

Bone Fragility in Diabetes: New Research Focuses on Diabetic Bone Disease

People with diabetes have an increased risk of fractures, which is often underdiagnosed and impacts their mobility as well as their mortality. A new array of treatments and assessments — novel therapeutics, senolytics, revamped prescribing protocols, and more — are needed to better concentrate on diabetic bone disease. An emerging complication of both type 1...

Bone and Mineral

Weightlifting Vegans May Have Stronger Bones than Others on Plant-Based Diets

People on a plant-based diet who do strength training as opposed to other forms of exercise such as biking or swimming may have stronger bones than other people on a vegan diet, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. About 6% of people in the U.S. are...

Flesh and Bone: New Research Upends the Conventional Wisdom About Body Weight and Bone Density in Men

For years, obesity was thought to have the ability to thwart the occurrence of osteoporosis, especially in men. However, a new study in The Journal of Clinical Endocrinology & Metabolism shows that men with obesity could be at a higher risk for osteoporosis than previously thought. Earlier this year, a paper entitled “Fat Mass Has...

Levels of AMH Could Predict or Detect Bone Loss in Premenopausal Women

Physicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone that declines as women approach their final menstrual period, according to a study recently published in Journal of Bone and Mineral Research. The findings could help physicians determine when, and...

Progression of Acromegalic Arthropathy Observed in Long-Term Study

Radiographic arthropathy progresses significantly in patients with long-term, well-controlled acromegaly, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Iris C. M. Pelsma, MD, MSc, of Leiden University Medical Center in The Netherlands, point out that one of the long-term complications of acromegaly is acromegalic arthropathy, which...

Researchers Develop First-in-Class Humanized Antibody Targeting Bone and Fat

A treatment for obesity and osteoporosis could be on the horizon as Mount Sinai researchers have developed a first-in-class humanized antibody to the follicle-stimulating hormone (FSH) that will reduce body fat, increase bone mass, enhance metabolism, and lower cholesterol. The antibody has the potential to prevent and treat obesity, osteoporosis, and hypercholesterolemia — diseases that...

More than Meets the Eye: Artificial Intelligence and X-Ray

Due to the “fractured” process of treating osteoporosis, Australian researchers and software developers teamed up to create a tool that uses artificial intelligence to read X-rays. The new program —XRAIT — has significantly improved fracture detection and could change the future of osteoporosis treatment. Christopher White, MBBS, PhD, FRACP, an endocrinologist at Prince of Wales...

Bone Health Experts Issue Osteoporosis Treatment Guidance During COVID-19

As the COVID-19 pandemic became more serious, the Endocrine Society joined a coalition of bone health organizations that united to issue new osteoporosis treatment guidelines. Aside from addressing the challenges social distancing has placed on treating these patients, the coalition has also focused on the administration of osteoporosis medications including denosumab, teriparatide, abaloparatide, romosozumab, and...

Bone and Mineral

Endocrine news on twitter